QX77: Molecular Chaperone Activator for Autophagy Research
2026-06-02
QX77 is a validated molecular chaperone activator that upregulates LAMP2A and Rab11, facilitating chaperone-mediated autophagy and stem cell differentiation. Its stable, research-only formulation enables robust autophagy pathway modulation in cellular systems. QX77 is particularly valuable for mechanistic studies of lysosomal receptor regulation and autophagy workflows.
Sulfamonomethoxine Workflows: Applied Protocols & Troublesho
2026-06-01
Sulfamonomethoxine (SMM) delivers consistent, broad-spectrum efficacy as a veterinary antibiotic, standing out for both experimental precision and environmental research. This guide unpacks optimized protocols, troubleshooting strategies, and real-world applications validated by recent studies.
Cy7 NHS Ester: Practical Guidance for Near-Infrared Labeling
2026-06-01
Cy7 NHS ester is a water-soluble, sulfonated near-infrared dye for efficient labeling of amino groups in proteins and peptides, supporting non-destructive in vivo and live-cell imaging. Its hydrophilicity and resistance to dye-dye quenching make it suitable for delicate biomolecules, but it is not recommended for workflows requiring long-term solution stability or for targets lacking accessible amino groups.
Cy5-UTP: Precision RNA Labeling for FISH & mRNA Delivery
2026-05-31
Cy5-UTP (Cyanine 5-uridine triphosphate) redefines RNA labeling with robust fluorescence, enabling direct visualization and multiplexed analysis in advanced molecular workflows. Its high incorporation efficiency and photostability streamline protocols for FISH, dual-color arrays, and nanoparticle-based mRNA delivery studies.
YAP-TEAD Mediates PPARα-Induced Liver Growth and Regeneratio
2026-05-30
This study elucidates the requirement of YAP-TEAD signaling for PPARα-driven hepatomegaly and liver regeneration in mice, using the selective agonist WY-14643 (Pirinixic Acid). Findings reveal a mechanistic connection between metabolic regulation and regenerative liver responses, offering a foundational framework for metabolic disorder and tissue repair research.
Biotin-HPDP (A8008): Reliable Thiol-Specific Protein Labelin
2026-05-29
This article provides a scenario-driven, evidence-based exploration of Biotin-HPDP (N-[6-(biotinamido)hexyl]-3’-(2’-pyridyldithio)propionamide), SKU A8008, for robust thiol-specific protein labeling. It addresses real-world experimental challenges in cell viability, redox, and affinity purification workflows, offering actionable guidance and validated best practices for biomedical researchers.
L-Alanyl-L-Glutamine: Precision Modulation of the Gut Barrie
2026-05-29
Explore how L-Alanyl-L-glutamine enables targeted intestinal mucosa protection and advanced modulation of barrier function. This article delivers a scientific deep dive into its unique biochemical actions, antioxidant support, and relevance for next-generation gastrointestinal research.
Bromodomain Inhibitor, (+)-JQ1: Reliable BET Assays with SKU
2026-05-28
This article provides scenario-driven guidance for scientists evaluating Bromodomain Inhibitor, (+)-JQ1 (SKU A1910) in cell viability, apoptosis, and inflammation assays. Drawing on validated research and comparative vendor analysis, it highlights how this BET bromodomain inhibitor enhances experimental reliability, reproducibility, and translational insight.
Hexetidine (NSC-17764): Applied Workflows for Oral Infection
2026-05-28
Hexetidine (NSC-17764) offers researchers a robust, broad-spectrum antimicrobial tool for oral infection and biofilm inhibition assays, with clear numeric guidance for concentration and workflow setup. This article delivers protocol-ready strategies, troubleshooting insights, and data-driven comparisons to maximize reproducibility and translational impact in oral health research.
Pexmetinib (ARRY-614): Optimizing Dual Pathway Inhibition Wo
2026-05-27
Pexmetinib (ARRY-614) is redefining dual kinase inhibition with robust suppression of cytokine synthesis and advanced control over p38 MAPK and Tie2 signaling. This article translates the latest mechanistic insights into actionable protocols, troubleshooting strategies, and future research implications for inflammation and myelodysplastic syndromes.
α-Amanitin in Transcriptional Regulation Research: Applied W
2026-05-27
Leverage α-Amanitin’s precise inhibition of RNA polymerase II to dissect transcriptional regulation and gene expression pathways. This guide details best-practices, protocol optimizations, and troubleshooting for advanced applications such as preimplantation embryo development studies and DNA damage response assays.
Colistin–Gamithromycin Synergy Against Pasteurella multocida
2026-05-26
Li et al. demonstrated that combining colistin with gamithromycin significantly enhances antibacterial efficacy against Pasteurella multocida in a neutropenic murine lung infection model. This study provides robust pharmacokinetic and pharmacodynamic evidence for synergistic therapy, with implications for optimizing treatment regimens against multidrug-resistant Gram-negative respiratory pathogens.
Cy5 Goat Anti-Mouse IgG (H+L) Antibody in Fluorescent Detect
2026-05-26
The Cy5 Goat Anti-Mouse IgG (H+L) Antibody empowers advanced fluorescent immunoassays with superior sensitivity and reproducibility. Its robust signal amplification and compatibility with complex workflows set new standards for mouse IgG detection, particularly in applications like next-generation vaccine development and multiplexed analysis.
p53/PUMA Apoptosis Underpins WRN Synthetic Lethality in MSI
2026-05-25
This study elucidates the molecular mechanism driving synthetic lethality between Werner helicase inhibition and mismatch repair deficiency in microsatellite instability (MSI) colorectal cancer. By identifying p53 and PUMA-mediated apoptosis as the critical pathway following WRN loss, the research provides a robust rationale for targeting WRN in p53-wildtype MSI CRCs.
Clozapine: Mechanisms and Protocols in Schizophrenia Researc
2026-05-25
Clozapine is an atypical antipsychotic medication with unique receptor affinities and ERK1/2 signaling effects. Its distinctive pharmacology supports advanced schizophrenia and neurotoxicity research. This article details molecular mechanisms, quantitative benchmarks, and workflow parameters for practitioners.
479 records 18/32 page Previous Next First page 上5页 1617181920 下5页 Last page